Primary Analysis of Spartan: A Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Patients with Sickle Cell Disease Related Priapism

Authors
Category Primary study
JournalBLOOD
Year 2023
This article has no abstract
Epistemonikos ID: b3bd5476d1808467af36347594eb82b5a3b276f4
First added on: Apr 29, 2024